These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 29610512)

  • 1. Risk of Interval Cancer in Fecal Immunochemical Test Screening Significantly Higher During the Summer Months: Results from the National Cancer Screening Program in Korea.
    Cha JM; Suh M; Kwak MS; Sung NY; Choi KS; Park B; Jun JK; Hwang SH; Lee DH; Kim BC; Lee YK; Han DS
    Am J Gastroenterol; 2018 Apr; 113(4):611-621. PubMed ID: 29610512
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Seasonal variations do not affect the superiority of fecal immunochemical tests over guaiac tests for colorectal cancer screening.
    Chausserie S; Levillain R; Puvinel J; Ferrand O; Ruiz A; Raginel T; Lantieri O; Launoy G; Guittet L
    Int J Cancer; 2015 Apr; 136(8):1827-34. PubMed ID: 25195670
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison of qualitative and quantitative fecal immunochemical tests in the Korean national colorectal cancer screening program.
    Park MJ; Choi KS; Lee YK; Jun JK; Lee HY
    Scand J Gastroenterol; 2012 Apr; 47(4):461-6. PubMed ID: 22428929
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fecal Immunochemical Test (FIT) for Colon Cancer Screening: Variable Performance with Ambient Temperature.
    Doubeni CA; Jensen CD; Fedewa SA; Quinn VP; Zauber AG; Schottinger JE; Corley DA; Levin TR
    J Am Board Fam Med; 2016 Nov; 29(6):672-681. PubMed ID: 28076249
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of seasonal variations in ambient temperatures on performance of immunochemical faecal occult blood test for colorectal cancer screening: observational study from the Florence district.
    Grazzini G; Ventura L; Zappa M; Ciatto S; Confortini M; Rapi S; Rubeca T; Visioli CB; Halloran SP
    Gut; 2010 Nov; 59(11):1511-5. PubMed ID: 20603498
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interval Colorectal Cancer Incidence Among Subjects Undergoing Multiple Rounds of Fecal Immunochemical Testing.
    van der Vlugt M; Grobbee EJ; Bossuyt PMM; Bos A; Bongers E; Spijker W; Kuipers EJ; Lansdorp-Vogelaar I; Spaander MCW; Dekker E
    Gastroenterology; 2017 Aug; 153(2):439-447.e2. PubMed ID: 28483499
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fresh vs Frozen Samples and Ambient Temperature Have Little Effect on Detection of Colorectal Cancer or Adenomas by a Fecal Immunochemical Test in a Colorectal Cancer Screening Cohort in Germany.
    Chen H; Werner S; Brenner H
    Clin Gastroenterol Hepatol; 2017 Oct; 15(10):1547-1556.e5. PubMed ID: 27793749
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk Factors for False Fecal Immunochemical Test Results in Colorectal Cancer Screening.
    Kim NH; Park JH; Park DI; Sohn CI; Choi K; Jung YS
    J Clin Gastroenterol; 2017 Feb; 51(2):151-159. PubMed ID: 27380459
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factors associated with false-positive and false-negative fecal immunochemical test results for colorectal cancer screening.
    Wong MC; Ching JY; Chan VC; Lam TY; Luk AK; Ng SS; Sung JJ
    Gastrointest Endosc; 2015 Mar; 81(3):596-607. PubMed ID: 25293827
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Real-Time Monitoring of Results During First Year of Dutch Colorectal Cancer Screening Program and Optimization by Altering Fecal Immunochemical Test Cut-Off Levels.
    Toes-Zoutendijk E; van Leerdam ME; Dekker E; van Hees F; Penning C; Nagtegaal I; van der Meulen MP; van Vuuren AJ; Kuipers EJ; Bonfrer JMG; Biermann K; Thomeer MGJ; van Veldhuizen H; Kroep S; van Ballegooijen M; Meijer GA; de Koning HJ; Spaander MCW; Lansdorp-Vogelaar I;
    Gastroenterology; 2017 Mar; 152(4):767-775.e2. PubMed ID: 27890769
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trends in the National Cancer Screening Program for colorectal cancer in the Republic of Korea, 2004-2009.
    Park MJ; Choi KS; Jun JK; Lee HY
    Asian Pac J Cancer Prev; 2011; 12(12):3489-93. PubMed ID: 22471503
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Participation, yield, and interval carcinomas in three rounds of biennial FIT-based colorectal cancer screening.
    Stegeman I; van Doorn SC; Mundt MW; Mallant-Hent RC; Bongers E; Elferink MA; Fockens P; Stroobants AK; Bossuyt PM; Dekker E
    Cancer Epidemiol; 2015 Jun; 39(3):388-93. PubMed ID: 25910865
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Disparities in the Participation Rate of Colorectal Cancer Screening by Fecal Occult Blood Test among People with Disabilities: A National Database Study in South Korea.
    Shin DW; Chang D; Jung JH; Han K; Kim SY; Choi KS; Lee WC; Park JH; Park JH
    Cancer Res Treat; 2020 Jan; 52(1):60-73. PubMed ID: 31096735
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contribution of the OC Sensor
    Vitellius C; Laly M; Banaszuk AS; Deherce I; Cornet N; Bertrais S; Saulnier P; Caroli-Bosc FX
    Eur J Epidemiol; 2019 Feb; 34(2):163-172. PubMed ID: 30536183
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fecal Occult Blood Test Results of the National Colorectal Cancer Screening Program in South Korea (2006-2013).
    Rim JH; Youk T; Kang JG; Park BK; Gee HY; Kim JH; Yoo J
    Sci Rep; 2017 Jun; 7(1):2804. PubMed ID: 28584248
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Validity of fecal occult blood test in the national cancer screening program, Korea.
    Shin A; Choi KS; Jun JK; Noh DK; Suh M; Jung KW; Kim BC; Oh JH; Park EC
    PLoS One; 2013; 8(11):e79292. PubMed ID: 24260189
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The fecal immunochemical test has high accuracy for detecting advanced colorectal neoplasia before age 50.
    Kim NH; Park JH; Park DI; Sohn CI; Choi K; Jung YS
    Dig Liver Dis; 2017 May; 49(5):557-561. PubMed ID: 28065631
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of season and ambient temperature on outcome of guaiac-based faecal occult blood tests performed for colorectal cancer screening.
    Hunter JP; Saratzis A; Froggatt P; Harmston C
    Colorectal Dis; 2012 Sep; 14(9):1084-9. PubMed ID: 22122559
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A higher detection rate for colorectal cancer and advanced adenomatous polyp for screening with immunochemical fecal occult blood test than guaiac fecal occult blood test, despite lower compliance rate. A prospective, controlled, feasibility study.
    Levi Z; Birkenfeld S; Vilkin A; Bar-Chana M; Lifshitz I; Chared M; Maoz E; Niv Y
    Int J Cancer; 2011 May; 128(10):2415-24. PubMed ID: 20658527
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Age-adapted Variation in Screening Interval of Fecal Immunochemical Test May Improve its Participation and Colonoscopy Acceptance.
    Kwak MS; Cha JM; Yoon JY; Jeon JW; Shin HP; Joo KR; Lee JI
    J Clin Gastroenterol; 2017 Oct; 51(9):825-830. PubMed ID: 27824639
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.